AMRI acquiring Aptuit assets, including UK aseptic site, in $60m deal
AMRI has paid $60m for two Aptuit facilities including an aseptic manufacturing site in Glasgow, UK which the firm says will boost its presence in Europe.
AMRI has paid $60m for two Aptuit facilities including an aseptic manufacturing site in Glasgow, UK which the firm says will boost its presence in Europe.
Hospira will resume the sale of infusion pumps from its troubled Costa Rica facility following the lifting of a US FDA import alert.
Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since 2008 according to the Pharmaceuticals and Medical Devices Agency (PDMA).
CROs are due to see an increasing workload in 2015, though the way they conduct trials with partners may continue to shift, according to the Tufts Center for the Study of Drug Development’s Outlook for 2015.
Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical industry group.
Horizon says its £6m (€7.7m) purchase of Austrian biotech Haplogen Genomics means it can produce cell lines ten times faster than before using a haploid gene platform.